IGHD4OR15-4B

Across TCGA pan-cancer cohorts, IGHD4OR15-4B RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated IGHD4OR15-4B data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher IGHD4OR15-4B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IGHD4OR15-4B expression acts as an unfavorable survival marker.

LUAD and LGG are the cancer types where IGHD4OR15-4B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.218	0.676	.014	18	view →
LGG	OS	Tertile	All	0.591	0.908	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IGHD4OR15-4B–LUAD (DFS)

Open the LUAD breakdown →